Development of biomarkers for Huntingtons disease: Revision history

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

    20 August 2022

    • curprev 06:5306:53, 20 August 2022‎ 187.21.138.9 talk‎ 381 bytes +381‎ Created page with "== Target Article == Development of biomarkers for Huntingtons disease; DW Weir, A Sturrock, B Leavitt; 2011; doi_citing_unknown == Retraction == Neurochemistry of Dopamine in Huntington's Dementia and Normal Aging ; Stephen M Stahl Sue Thiemann Kym F Faull Jack D Barchas Philip A Berger; 02/01/1986 ; doi_cited_unknown == Citation piece == Note: Open to append information."
Retrieved from "https://wikicitingretracted.org/index.php?title=Development_of_biomarkers_for_Huntingtons_disease"